Share Prices & Company Research

Market News

15 Nov 2024 | 08:08

Europe open: Pharma shares hit as Trump appoints Kennedy to head health

(Sharecast News) - European equity markets opened weaker on Friday with pharma stocks lower on news that Robert F. Kennedy Jr - who has made misleading statements on vaccines - had been appointed as Donald Trump's head of health. The pan-European Stoxx 600 index was down 0.79% at 502.88 in early deals with all major bourses in the red.

Trump late on Thursday nominated Kennedy, who last year said he believe autism was caused by vaccines, to lead the Department of Health and Human Services in his new administration when it takes power next January.

Pharmaceutical stocks such as GSK, Sanofi, Swedish Orphan Biovitrum, UCB, Sartorius Stedim, Zealand Pharma and Roche were all knocked by the news.

In positive news for the sector, shares in Evotec surged as the German drug developer received an €11-per-share offer from Halozyme Therapeutics, valuing the company at about €2bn.

Generali also jumped as the Italian insurer posted better-than-expected 9-month profits.

Reporting by Frank Prenesti for Sharecast.com
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new portfolio or transferring your portfolio from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.